Literature DB >> 27844195

[Event recorder in cryptogenic stroke : Accepted and feasible indications].

J Brachmann1, M Held2.   

Abstract

It was proven in multiple studies that about 30 % of cryptogenic strokes are related to clinically silent atrial fibrillation (AF). There is an opportunity for prolonged ECG monitoring mainly through an implanted event recorder after completion of conventional diagnostic methods in an unidentified stroke source. The Crystal AF study has proven, together with other results, improved AF detection through prolonged monitoring for up to 36 months. An implanted event recorder for 2-3 years is suitable for this particular purpose. In addition, telemonitoring which is available in some recent models offers prompt detection and allows necessary therapies (e.g., oral anticoagulants) to be initiated. The implantation of an event recorder should also be considered in patients with a previous history of neurological symptoms in the context of undetectable sources of stroke or transient ischemic attack (TIA).

Entities:  

Keywords:  Cryptogenic stroke; Crystal AF Trial; Event recorder; Neurologic symptoms; Telemonitoring

Mesh:

Year:  2016        PMID: 27844195     DOI: 10.1007/s00399-016-0473-z

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  10 in total

Review 1.  Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials.

Authors:  David M Kent; Issa J Dahabreh; Robin Ruthazer; Anthony J Furlan; Mark Reisman; John D Carroll; Jeffrey L Saver; Richard W Smalling; Peter Jüni; Heinrich P Mattle; Bernhard Meier; David E Thaler
Journal:  J Am Coll Cardiol       Date:  2016-03-01       Impact factor: 24.094

2.  Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study.

Authors:  Irene Meissner; Bijoy K Khandheria; John A Heit; George W Petty; Sheldon G Sheps; Gary L Schwartz; Jack P Whisnant; David O Wiebers; Jody L Covalt; Tanya M Petterson; Teresa J H Christianson; Yoram Agmon
Journal:  J Am Coll Cardiol       Date:  2005-12-06       Impact factor: 24.094

3.  The Evolution and Application of Cardiac Monitoring for Occult Atrial Fibrillation in Cryptogenic Stroke and TIA.

Authors:  Daniel J Miller; Kavit Shah; Sumul Modi; Abhimanyu Mahajan; Salman Zahoor; Muhammad Affan
Journal:  Curr Treat Options Neurol       Date:  2016-04       Impact factor: 3.598

4.  Detection of Silent Atrial Fibrillation aFter Ischemic StrOke (SAFFO) guided by implantable loop recorder: multicentre Italian trial based on stroke unit network with paired cardio-arrhythmology units (Italian Neurocardiology Unit Network).

Authors:  Danilo Toni; Svetlana Lorenzano; Stefano Strano
Journal:  Int J Stroke       Date:  2016-02-12       Impact factor: 5.266

5.  Atrial fibrillation in patients with cryptogenic stroke.

Authors:  David J Gladstone; Melanie Spring; Paul Dorian; Val Panzov; Kevin E Thorpe; Judith Hall; Haris Vaid; Martin O'Donnell; Andreas Laupacis; Robert Côté; Mukul Sharma; John A Blakely; Ashfaq Shuaib; Vladimir Hachinski; Shelagh B Coutts; Demetrios J Sahlas; Phil Teal; Samuel Yip; J David Spence; Brian Buck; Steve Verreault; Leanne K Casaubon; Andrew Penn; Daniel Selchen; Albert Jin; David Howse; Manu Mehdiratta; Karl Boyle; Richard Aviv; Moira K Kapral; Muhammad Mamdani
Journal:  N Engl J Med       Date:  2014-06-26       Impact factor: 91.245

6.  Cryptogenic stroke and underlying atrial fibrillation.

Authors:  Tommaso Sanna; Hans-Christoph Diener; Rod S Passman; Vincenzo Di Lazzaro; Richard A Bernstein; Carlos A Morillo; Marilyn Mollman Rymer; Vincent Thijs; Tyson Rogers; Frank Beckers; Kate Lindborg; Johannes Brachmann
Journal:  N Engl J Med       Date:  2014-06-26       Impact factor: 91.245

7.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

8.  Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial.

Authors:  Johannes Brachmann; Carlos A Morillo; Tommaso Sanna; Vincenzo Di Lazzaro; Hans-Christoph Diener; Richard A Bernstein; Marylin Rymer; Paul D Ziegler; Shufeng Liu; Rod S Passman
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-01

9.  Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

Authors:  John D Carroll; Jeffrey L Saver; David E Thaler; Richard W Smalling; Scott Berry; Lee A MacDonald; David S Marks; David L Tirschwell
Journal:  N Engl J Med       Date:  2013-03-21       Impact factor: 91.245

10.  Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study.

Authors:  Rolf Wachter; Mark Weber-Krüger; Joachim Seegers; Frank Edelmann; Janin Wohlfahrt; Katrin Wasser; Götz Gelbrich; Gerd Hasenfuß; Raoul Stahrenberg; Jan Liman; Klaus Gröschel
Journal:  J Neurol       Date:  2013-05-01       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.